RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

By giving Samyang such a big stake in the company, the incentive to string cor along with a bogus partnership negotiation, with the ultimate goal of scooping up the IP is no longer in place. If a deal isn't done, cor will shareprice will drift downward, and Samyang walks off with the IP.

Also cor management's interests are in alignment with shareholders again: the higher the shareprice at the time of conversion, the smaller the stake Samyang will ultimately have.